HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Giovanna Rege-Cambrin Selected Research

eltrombopag

4/2020Pure red cell aplasia and amegakaryocytic thrombocytopenia in thymoma: The uncharted territory.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Giovanna Rege-Cambrin Research Topics

Disease

25BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2022 - 07/2002
6Philadelphia Chromosome
01/2021 - 06/2002
5Leukemia
12/2019 - 06/2002
4Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
09/2013 - 05/2007
3Neoplasms (Cancer)
01/2021 - 01/2017
2Residual Neoplasm
10/2021 - 02/2002
2Cytopenia
04/2020 - 10/2007
2Pleural Effusion (Pleural Effusions)
01/2018 - 10/2011
2Chromosome Aberrations (Chromosome Abnormalities)
04/2015 - 07/2012
2Blast Crisis (Blast Phase)
11/2011 - 12/2008
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2011 - 02/2002
2Pathologic Complete Response
02/2009 - 12/2008
1Infections
01/2022
1Hematologic Diseases (Blood Diseases)
12/2019
1Genomic Instability
04/2015
1Acute Promyelocytic Leukemia
08/2014
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
08/2014
1Lung Neoplasms (Lung Cancer)
10/2011
1Breast Neoplasms (Breast Cancer)
10/2011
1Head and Neck Neoplasms (Head and Neck Cancer)
10/2011
1Febrile Neutropenia
10/2007
1Drug-Related Side Effects and Adverse Reactions
10/2007

Drug/Important Bio-Agent (IBA)

17Imatinib Mesylate (Gleevec)FDA Link
11/2016 - 09/2004
12Tyrosine Kinase InhibitorsIBA
01/2022 - 12/2004
4Dasatinib (BMS 354825)FDA Link
01/2018 - 10/2007
3Proteins (Proteins, Gene)FDA Link
01/2021 - 12/2004
2nilotinibFDA Link
10/2022 - 01/2016
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2021 - 12/2004
2Interferon-alpha (Interferon Alfa)IBA
08/2010 - 05/2008
2bcr-abl Fusion ProteinsIBA
12/2004 - 09/2004
1Messenger RNA (mRNA)IBA
10/2021
1eltrombopagFDA Link
04/2020
1amsonic acid (DAS)IBA
01/2018
1CalreticulinIBA
01/2017
1Janus Kinase 2IBA
01/2017
1Tretinoin (Retinoic Acid)FDA LinkGeneric
08/2014
1Pharmaceutical PreparationsIBA
10/2011
1SuspensionsIBA
10/2011
1Biomarkers (Surrogate Marker)IBA
02/2009
1SteroidsIBA
05/2007
1MB 5IBA
07/2002

Therapy/Procedure

15Therapeutics
01/2022 - 02/2002
2Stem Cell Transplantation
11/2011 - 12/2008
1Polypharmacy
11/2016
1Transplantation
11/2011
1Drug Tapering
10/2007
1Drug Therapy (Chemotherapy)
05/2007
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
02/2002